{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-199606","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2022-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.306123+00:00","generated_at":"2026-06-24T09:44:39.833628+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HCA Healthcare Q2 2022 net income down 20% to $1.155B; EPS $3.90 vs $4.36 YoY","bullets":["Revenue $14.820B (+2.7% YoY); net income $1.155B ($3.90 EPS) vs $1.450B ($4.36) in Q2 2021.","Adjusted EBITDA $3.042B (-5.5% YoY); same facility admissions -1.2%, equivalent admissions +0.5%.","Operating cash flow $1.630B vs $2.251B in Q2 2021; capital expenditures $1.080B (ex-acquisitions).","Repurchased 12.23M shares for $2.682B in Q2; $3.803B remaining under repurchase authorization.","Board declared $0.56 quarterly dividend, payable Sept 30 to holders of record Sept 16."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-199606","json":"https://secwatch.observer/filing/0001193125-22-199606.json","markdown":"https://secwatch.observer/filing/0001193125-22-199606.md","text":"https://secwatch.observer/filing/0001193125-22-199606.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/0001193125-22-199606-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/d383183d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T09:44:39.833628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}